|
|
|
|||||||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
Key: Meeting
Showing releases 76-100 out of 951. << < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 > >>
Public Release: 13-Mar-2013
 NatureTapeworm DNA contains drug weak spots Tapeworms cause devastating disease around the world and new treatments are urgently needed. This study describes possible targets on which currently licensed drugs could act, identified by genome sequencing. Re-using existing therapies will help to develop treatments more rapidly. Contact: Aileen Sheehy
Public Release: 12-Mar-2013
Proceedings of the National Academy of SciencesPrediction of seasonal flu strains improves chances of universal vaccine Researchers have determined a way to predict and protect against new strains of the flu virus, in the hope of improving immunity against the disease. Contact: Rebecca Scott
Public Release: 12-Mar-2013
Environmental Health PerspectivesPrenatal exposure to pesticide DDT linked to adult high blood pressure Infant girls exposed to high levels of the pesticide DDT while still inside the womb are three times more likely to develop hypertension when they become adults, according to a new study led by the University of California, Davis. 
National Institutes of Health
Contact: Michele La Merrill
Public Release: 12-Mar-2013
PLOS MedicineImplementing e-health in Malawi In this week's PLOS Medicine, Miguel SanJoaquin from the University of Malawi College of Medicine and colleagues describe their experience of implementing an electronic patient record system in a large referral hospital in southern Malawi. Contact: Sumrina Yousufzai
Public Release: 12-Mar-2013
PLOS MedicinePreventing HIV infection with anti-HIV drugs in people at risk is cost-effective An HIV prevention strategy in which people at risk of becoming exposed to HIV take antiretroviral drugs to reduce their chance of becoming infected (often referred to as pre-exposure prophylaxis or PrEP), may be a cost-effective method of preventing HIV in some settings, according to a study by international researchers published in this week's PLOS Medicine. Contact: Sumrina Yousufzai
Public Release: 11-Mar-2013
Epilepsy & BehaviorPeer support shows promise in epilepsy fight Peer support groups show promise for combating the debilitating stigma that surrounds epilepsy in much of the developing world, according to a new study led by a Michigan State University medical student.
NIH/National Institute of Neurological Disorders and Stroke
Contact: Andy McGlashen
Public Release: 7-Mar-2013
Journal of Theoretical BiologyNet advantage Malaria, the leading cause of death among children in Africa, could be eliminated if three-fourths of the population used insecticide-treated bed nets, according to a new study from the National Institute for Mathematical and Biological Synthesis.
National Institute for Mathematical and Biological Synthesis
Contact: Catherine Crawley
Public Release: 7-Mar-2013
PediatricsStudy: Computerized reminders significantly improve HIV care in resource-limited setting A large randomized controlled study led by Regenstrief Institute and Indiana University School of Medicine researchers is among the first to rigorously demonstrate that health information technology can improve compliance with patient care guidelines by clinicians in resource-limited countries.
Abbott Fund, Centers for Disease Control and Prevention
Contact: Cindy Fox Aisen
Public Release: 7-Mar-2013
American Academy of Microbiology releases resistance report What do cancer cells, weeds, and pathogens have in common? They all evolve resistance to the treatments that are supposed to eliminate them. However, researchers developing the next generation of antibiotics, herbicides, and anti-cancer therapeutics rarely come together to explore the common evolutionary principles at work across their different biological systems. Contact: Garth Hogan
Public Release: 5-Mar-2013
5th Regional Pneumococcal SymposiumNew study suggests potential shift in burden of pneumococcal disease New studies revealed today by Latin-American researchers and global health leaders suggest that the highest burden of deadly pneumococcal disease in Latin America may be shifting to adults as countries successfully immunize more infants with new vaccines. The experts called for increased disease monitoring and more surveillance to understand the full extent of pneumococcal disease in the Americas, including its economic impact, and to devise effective strategies to prevent it.
Sabin Vaccine Institute
Contact: Johanna Harvey
Public Release: 5-Mar-2013
PLOS MedicineSharing HIV research findings with participants Is it feasible to share research findings with HIV-infected participants enrolled in observational research in rural sub-Saharan African? Anna Baylor and colleagues orally disseminated their findings to 477 research participants during a meeting modelled on a traditional wedding event. Contact: Sumrina Yousufzai
Public Release: 5-Mar-2013
PLOS MedicineResistance to first line anti-malarial drugs is increasing on the Thai-Myanmar border Early diagnosis and treatment with antimalarial drugs (ACTs -- artemisinin based combination treatments) has been linked to a reduction in malaria in the migrant population living on the Thai-Myanmar border, despite evidence of increasing resistance to ACTs in this location, according to a study by international researchers published in this week's PLOS Medicine. Contact: Sumrina Yousufzai
Public Release: 4-Mar-2013
PLOS ONEVitamin deficiency screening needed for refugees New research from the University of Adelaide has discovered a high prevalence of vitamin B12 deficiency among refugees, prompting calls for refugees to be routinely screened for the problem soon after they arrive. Contact: Dr. Jill Benson
Public Release: 4-Mar-2013
20th Conference on Retroviruses and Opportunistic InfectionsStudy of tenofovir vaginal gel shows daily dosing ineffective due to lack of adherence Researchers with the Microbicide Trials Network today announced results of the Vaginal and Oral Interventions to Control the Epidemic study at the Conference for Retroviruses and Opportunistic Infections in Atlanta, Georgia. Contact: Annette Larkin
Public Release: 4-Mar-2013
Annals of Internal MedicineStudies advance knowledge of HIV impact on hepatitis C infection and genes that may thwart HCV Infectious disease experts at Johns Hopkins have found that among people infected with the hepatitis C virus, co-infection with HIV, speeds damage and scarring of liver tissue by almost a decade. Contact: David March
Public Release: 4-Mar-2013
Sanford-Burnham and 60° Pharmaceuticals to pursue promising target for the treatment of dengue fever Sanford-Burnham Medical Research Institute and 60° Pharmaceuticals have entered into a partnership to test furin, a human proteinase, as a drug target for the treatment of dengue fever, one of the most common infectious diseases in the tropics and subtropics. Contact: Deborah Robison
Public Release: 4-Mar-2013
LancetNew data show countries around the world grappling with changing health challenges Alzheimer's disease is the fastest growing threat to health in the US. HIV/AIDS and alcohol are severely eroding the health of Russians. Violence is claiming the lives of young men in large swaths of Latin America. Despite health gains in sub-Saharan Africa, infectious diseases still cause hundreds of thousands of child deaths. These findings will be announced on March 5 at the Bill & Melinda Gates Foundation in Seattle, by IHME Director Dr. Christopher Murray and Bill Gates.
Bill & Melinda Gates Foundation
Contact: Rhonda Stewart
Public Release: 3-Mar-2013
Nature Climate ChangeEarly warning system provides 4-month forecast of malaria epidemics in northwest India Sea surface temperatures in the tropical South Atlantic Ocean can be used to accurately forecast, by up to four months, malaria epidemics thousands of miles away in northwestern India, a University of Michigan theoretical ecologist and her colleagues have found.
National Institute of Malaria Research New Delhi, University of Michigan/Graham Sustainability Institute, NOAA, National Science Foundation, NASA
Contact: Jim Erickson
Public Release: 28-Feb-2013
Human trials for Streptococcus A vaccine Griffith University's Institute for Glycomics has launched human trials for a vaccine against Streptococcus A, the germ that causes rheumatic fever.
Queensland Institute of Medical Research
Contact: Helen Wright
Public Release: 28-Feb-2013
ScienceWolf in sheep's clothing: Uncovering how deadly bacteria trick the immune system A new UCLA study demonstrates how bacteria can pretend to be a virus and trick the immune system into sending out the wrong type of defense. Such manipulation sheds light on how the flu may make us more susceptible to pneumonia or as in the recent outbreak of TB in Los Angeles, possibly how the flu and other environmental factors could be used to the TB bacteria's advantage.
NIH/National Institute of Arthritis and Musculoskeletal Skin Diseases
Contact: Rachel Champeau
Public Release: 28-Feb-2013
PLOS Neglected Tropical DiseasesDeworming important for children's health, has limited impact on infection in wider communities Although they have an important impact on children's health and education, school-based deworming programs have a limited impact on the level of infection in the wider community, according to a mathematical modeling study conducted by researchers at Imperial College London. Contact: Sam Wong
Public Release: 27-Feb-2013
PLOS ONERapid, point-of-care tests for syphilis: The future of diagnosis An international research team, led by the Research Institute of the McGill University Health Centre, has demonstrated that rapid and point-of-care tests (POC) for syphilis are as accurate as conventional laboratory tests. The findings, which were published in PLOS ONE, call for a major change in approach to syphilis testing and recommend replacing first line laboratory tests with POC tests globally, especially in resource-limited settings.
Canadian Institutes of Health Research
Contact: Julie Robert
Public Release: 27-Feb-2013
NatureNew study shows viruses can have immune systems A study published today in Nature reports that a viral predator of the cholera bacteria has stolen the functional immune system of bacteria and is using it against its bacterial host. This provides the first evidence that this type of virus, the bacteriophage, can acquire an adaptive immune system. The study has implications for phage therapy, the use of phages to treat bacterial diseases.
NIH/National Institute of Allergies and Infectious Diseases
Contact: Siobhan Gallagher
Public Release: 26-Feb-2013
DNDi receives BBVA Foundation award for delivering new treatments for neglected diseases Today in Madrid, Spain, the Drugs for Neglected Diseases initiative received the BBVA Foundation 'Frontiers of Knowledge and Culture Award for Development Cooperation'. This EUR 400,000 award will be presented at a ceremony in Madrid, Spain, in June of this year. Contact: Violaine Dällenbach
Public Release: 26-Feb-2013
Breakthrough camera to improve detection of blinding eye disease and diabetes The world's first intelligent retinal camera will accurately and rapidly detect and eventually diagnose sight-threatening conditions such as diabetic retinopathy and glaucoma. The camera is being designed for ease of use in the most extreme environments so that it can be used by technical support staff and in the most remote and under-served locations, especially to close the gap in eye health in Australian Aboriginal communities. Contact: Stephen Davis
Showing releases 76-100 out of 951. << < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 > >>
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||
|
|
 |
|
